Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
University of Pittsburgh
University of Pittsburgh
University of Pittsburgh
National Cancer Institute, Egypt
M.D. Anderson Cancer Center
University of Chicago
Istituto Oncologico Veneto IRCCS
Icahn School of Medicine at Mount Sinai
Royal Marsden NHS Foundation Trust
Washington University School of Medicine
Medical University of South Carolina
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
HĂ´pital NOVO
Wake Forest University Health Sciences
M.D. Anderson Cancer Center
UNC Lineberger Comprehensive Cancer Center
Case Comprehensive Cancer Center
Memorial Sloan Kettering Cancer Center
Vanderbilt-Ingram Cancer Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Dutch Society of Physicians for Pulmonology and Tuberculosis
M.D. Anderson Cancer Center
Vanderbilt-Ingram Cancer Center
Seoul National University Bundang Hospital
Salzburger Landeskliniken
UNC Lineberger Comprehensive Cancer Center
Abramson Cancer Center at Penn Medicine
University of Maryland, Baltimore
University Hospital, Brest
Azienda Ospedaliero-Universitaria di Parma
University of Oklahoma
UNC Lineberger Comprehensive Cancer Center
Northwestern University
NRG Oncology
Massachusetts General Hospital
University of Colorado, Denver
UNC Lineberger Comprehensive Cancer Center
University of Chicago
University of Pittsburgh
Maastricht University Medical Center
Mashhad University of Medical Sciences
Centre Henri Becquerel
Rigshospitalet, Denmark
Rochester Dermatologic Surgery
Memorial Sloan Kettering Cancer Center
Hospices Civils de Lyon
Institut de Cancérologie de Lorraine
Mayo Clinic
H. Lee Moffitt Cancer Center and Research Institute